95 filings
Page 5 of 5
8-K
b1s0h stjmm
27 May 22
Regulation FD Disclosure
6:01am
8-K/A
gjm5biamfnvs yt4847
19 May 22
Correction Notice to Press Release Announcing Financial Results For the Fourth Quarter and Full Year 2021 Financial Results and Corporate Update
6:05am
8-K
wacx02ccgvqw 2x2
16 May 22
Allarity Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update
7:54pm
8-K
3w6nd xbnwedqp
6 May 22
Entry into a Material Definitive Agreement
5:09pm
8-K
ioi46
22 Apr 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:28pm
8-K
5xm2v wb33qjcfbatc2
18 Apr 22
Entry into a Material Definitive Agreement
5:06pm
8-K
rahtr
1 Apr 22
Entry into a Material Definitive Agreement
4:50pm
8-K/A
fs827bpto0 n1bqs
1 Apr 22
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
4:30pm
8-K
cs92ckq98kloccen1
31 Mar 22
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
5:16pm
8-K
ypi90xh9 plq3mv26
18 Jan 22
Regulation FD Disclosure
12:00am
8-K
2qm 9yiwvp2iz6r8q0nn
6 Jan 22
Entry into a Material Definitive Agreement
4:30pm
8-K
zvm qfut92fc94u
22 Dec 21
Changes in Registrant's Certifying Accountant
5:05pm
8-K
xp6x z4lbdjcez
22 Dec 21
Allarity Therapeutics Closes Its Recapitalization, Share Exchange, and $20M PIPE Investment; Lists on U.S. Nasdaq Stock Market
5:00pm
8-K
cdk0tblkmzen0yqysdu
20 Dec 21
Material Modifications to Rights of Security Holders
4:30pm
8-K
pqfmv4v
10 Dec 21
Entry into a Material Definitive Agreement
4:34pm